Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2000
10/17/2000US6133245 Introducing into cell an inducible tissue specific antisense dna construct comprising coding sequence of inducible tissue specific gene product into which dna sequence antisense to dna sequence of gene targeted for regulation has been inserted
10/17/2000US6133229 Stabilizing aqueous enzyme with aqueous solution comprising tris/hydroxymethyl/methyl compound, cationic polyelectrolyte, polyol, salt of calcium, magnesium and/or cobalt
10/17/2000US6133220 Detergent compositions containing a lipase variant at low levels
10/17/2000US6133034 Methods and compositions related to the production of trehalose
10/17/2000US6133029 Replication defective viral vectors for infecting human cells
10/17/2000US6133016 Sphingomonas biodesulfurization catalyst
10/17/2000US6133014 Maleate isomerase gene
10/17/2000US6133013 Nucleotide sequence coding protein with clot dissolving activity; for treatment blood coagulation defects
10/17/2000US6133012 Thermostable acyl peptide hydrolase and gene encoding the same
10/17/2000US6133011 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
10/17/2000US6133009 Type II Restriction endonuclease, HpyCH4V, obtainable from helicobacter pylori CH4 and a process for producing the same
10/17/2000US6133008 Method for cloning and producing the TfiI Restriction endonuclease in E. coli
10/17/2000US6133007 Phosphodiesterase 8A
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6133005 Enzymatic protein; for the treatment of nervous system disorders associated with thamine vitamin deficiency
10/17/2000US6132983 Microorganismal protein with enzymatic activity associated with luminescence
10/17/2000US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
10/17/2000US6132973 Nucleotide sequence coding protein associated with gene expression; for the diagnosis, prevention, and treatment of defects associated with cell proliferation
10/17/2000US6132970 Rearranging nucleotide sequences; extending chains of nucleotide sequence with regions of both homogeneity and heterogeneity in multiple cycles, screening rearranged nucleotide sequences to detect desired properties
10/17/2000US6132967 Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)
10/17/2000US6132966 Enzymatic nucleic acid which specifically prevents viral replication; for the treatment of transformed hepatocytes and suppression of viral infection humans, animals and primates
10/17/2000US6132964 Complementarity nucleotide sequences coding polypeptide with catalytic activity; for diagnosis and detection of cell proliferation and autoimmune diseases and viral, bacterial, fungal, parasitic, protozoal, and helminthic infections
10/17/2000US6132962 Plasmid coding ribozyme; for the prevention of viral infection
10/17/2000US6132722 Recombinant antibody-enzyme fusion proteins
10/17/2000US6132717 Administering to said mammals an endoproteolytically active amount of furin produced by a eukaryotic host cell.
10/17/2000US6132716 Thermostable xylanases from Microtetraspora flexuosa as a feed additive
10/17/2000US6132714 Human growth-associated methyltransferases
10/17/2000US6132713 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
10/17/2000US6132712 Superoxide dismutase stabilized with fragments of casein and pharmaceutical compositions incorporating same
10/17/2000US6132711 Enzymatic antioxidant of allene oxide for lipid peroxidation in biological systems
10/17/2000US6131578 Inhibitors of UDP-G1cNAc:Ga1β1-3Ga1NAcαR β1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes
10/17/2000CA1341123C Filamentous hemagglutinin of b. pertussis
10/12/2000WO2000060109A1 Amplification of cyp24 and uses thereof
10/12/2000WO2000060105A1 murA
10/12/2000WO2000060101A1 Metabolic selection markers for plants
10/12/2000WO2000060100A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000WO2000060099A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000WO2000060098A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000WO2000060097A1 Plant rna-directed rna polymerase proteins
10/12/2000WO2000060096A1 Thermostable enzyme having aminotransferase activity and gene encoding the same
10/12/2000WO2000060095A2 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes
10/12/2000WO2000060094A1 Modified lactococci expressing a catalase and their uses
10/12/2000WO2000060093A1 Linoleate and linolenate-lipoxygenase mutants
10/12/2000WO2000060092A2 Dsp-3 dual-specificity phosphatase
10/12/2000WO2000060091A2 Method for selecting recombinase variants with altered specificity
10/12/2000WO2000060076A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000WO2000060072A1 Polynucleotide synthesis using a processing enzyme
10/12/2000WO2000060067A1 Cathepsin d regulatory element
10/12/2000WO2000060064A1 A purification process for a calcium binding type enzyme, such as a metalloprotease, using a calcium free buffer
10/12/2000WO2000060063A1 Lipase variant
10/12/2000WO2000060062A2 Human signal transduction serine/threonine protein kinase
10/12/2000WO2000060061A2 Transgenic plant resistant to mycotoxins and methods
10/12/2000WO2000060060A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same
10/12/2000WO2000060059A2 Alpha-amylase variants
10/12/2000WO2000060058A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same
10/12/2000WO2000059924A1 Methods and reagents for modulating caspase-mediated apoptosis
10/12/2000WO2000059919A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000032756A3 Sequenzes of a putative plant diacylglycerol acyltransferases
10/12/2000WO2000020566A3 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto
10/12/2000WO2000018918A9 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
10/12/2000WO2000017232A3 Regulatory protein from human keratinocytes
10/12/2000WO2000015790A9 Leptin induced genes
10/12/2000WO1999041376A8 Retinoblastoma protein complexes and retinoblastoma interacting proteins
10/12/2000WO1999027107A9 Gram-positive microorganism formate transporters
10/12/2000DE19916140A1 Carotinhydroxylase und Verfahren zur Herstellung von Xanthophyllderivaten Carotene hydroxylase and method of producing Xanthophyllderivaten
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2367403A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000CA2367396A1 Method for selecting recombinase variants with altered specificity
10/12/2000CA2367269A1 Polynucleotide synthesis using a processing enzyme
10/12/2000CA2367258A1 Linoleate and linolenate-lipoxygenase mutants
10/12/2000CA2367109A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000CA2367104A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000CA2366843A1 Lipase variant
10/12/2000CA2365438A1 Alpha-amylase variants
10/12/2000CA2365221A1 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000CA2305085A1 A global test for evaluating the functionality of the thrombin/antithrombin system
10/11/2000EP1043406A1 Analysis of predisposition based on human airway tripsin protease gene polymorphism
10/11/2000EP1043398A1 Expression vector pUC NT, DNA coding for decarbamylase improved in thermostability and use thereof
10/11/2000EP1043397A1 IDENTIFICATION OF NOVEL SUBSTRATE I-TRAF OF IKK-i KINASE
10/11/2000EP1043394A2 Combination containing prostate-specific-antigen (PSA)
10/11/2000EP1043393A2 Method for the purification of lactoperoxidase
10/11/2000EP1043328A1 Novel physiologically active substance sulphostin, process for producing the same, and use thereof
10/11/2000EP1042510A1 Method of selecting flanking sequences which convey relative binding affinities to a ligand binding site
10/11/2000EP1042490A2 Proteases from gram positive organisms
10/11/2000EP1042489A2 Proteases from gram positive organisms
10/11/2000EP1042488A2 Proteases from gram positive organisms
10/11/2000EP1042487A2 Proteases from gram positive organisms
10/11/2000EP1042486A1 Plant galactose dehydrogenase
10/11/2000EP1042485A2 Desaturase
10/11/2000EP1042484A1 Plant isocitrate dehydrogenase homologs
10/11/2000EP1042483A2 Increase of nodule number and nitrogen fixation in leguminosae
10/11/2000EP1042482A1 Acetyl-coa-carboxylase from candida albicans
10/11/2000EP1042463A1 Target for treating atherosclerosis, obesity and type ii diabetes
10/11/2000EP1042461A2 Expression cloning in filamentous fungi
10/11/2000EP1042457A1 Polypeptides having aminopeptidase activity and nucleic acids encoding same
10/11/2000EP1042456A1 Human nucleotide pyrophosphohydrolase-2
10/11/2000EP1042455A1 HUMAN CYCLIN-DEPENDENT KINASE $i((h)PFTAIRE)
10/11/2000EP1042454A1 Modified enzymes comprising a polyanionic domain
10/11/2000EP1042451A1 Linoleate isomerase